Empowering purpose-driven, early-stage innovation in drug discovery and development via access to Elsevier’s comprehensive suite of R&D solutions for Pharma and Life Sciences.
Enter your email address to follow the Hive and get the latest updates on participants and milestones
Real Stories. Real Science. Real Time.
The Hive is a collaboration project through which Elsevier R&D Solutions works with a select group of biotech and pharmaceutical startups to raise the visibility of their work in early stage drug discovery and development research and share lessons in overcoming pharma R&D challenges. Elsevier announces that it has selected the companies to take part in The Hive
this year. These companies exemplify the fresh, innovative, and agile world of R&D that is taking place outside the walls of Big Pharma that has the potential to change the industry’s landscape and improve the lives of patients. Meet our participants and sign up to follow their first-person stories of drug discovery and development.
Repurposing drugs helps patients with rare diseases
Dr. Nicolas Sireau, founder of Findacure, knows the frustration of watching his own children suffer from a rare debilitating disease, alkaptonuria. Learn how Elsevier is working with Findacure to enable the study of rare disease mechanisms, pairing information and analytics to assess the biological make-up of disease and shortlist the most promising potential treatments that could be repurposed safely and effectively.
Learn More About Elsevier R&D Solutions for
Early Stage Drug Discovery and Development:
Improve R&D productivity with a chemistry research solution that delivers experimental facts on chemical structures, properties, reactions and procedures.
Reaxys Medicinal Chemistry
Empower hit identification and lead optimization with normalized compound–target affinity data and comprehensive pharmacokinetic, efficacy, toxicity, safety and metabolic profiles.
Increase the discovery of biomedical evidence to support critical life sciences functions, with access to the world's most comprehensive biomedical literature database.
Enable better informed preclinical drug safety decisions with comprehensive, fully searchable FDA/EMA drug approval documents and comparative extracted drug safety data.
Reduce time spent monitoring, organizing and annotating scientific and medical literature for triage and compliance reports such as PSURs and ICSRs.
Enable better understanding of biological processes underlying disease progression and treatment response, with a solution that helps researchers interpret experimental data from scientific literature.
Drive pharmaceutical research towards innovative directions by working with Elsevier's Professional Services team to resolve challenges with data quality and integration.
Get meaningful answers to complex pharma R&D research questions through Elsevier's custom Text Mining service that enables the retrieval of highly specified information from unstructured content.
Enable researchers to more effectively and efficiently search authoritative, fulltext scientific, technical and health content through the use of smart, intuitive functionality.
Help researchers discover trends, partners and experts with the world’s largest abstract & citation database of peerreviewed literature, including tools to track, analyze and visualize research.